These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10666145)
1. Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state. Cincotta AH; Luo S; Zhang Y; Liang Y; Bina KG; Jetton TL; Scislowski PW Am J Physiol Regul Integr Comp Physiol; 2000 Feb; 278(2):R435-44. PubMed ID: 10666145 [TBL] [Abstract][Full Text] [Related]
2. Chronic ventromedial hypothalamic infusion of norepinephrine and serotonin promotes insulin resistance and glucose intolerance. Luo S; Luo J; Cincotta AH Neuroendocrinology; 1999 Dec; 70(6):460-5. PubMed ID: 10657739 [TBL] [Abstract][Full Text] [Related]
3. Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: relation to the metabolic syndrome. Kraszewski KZ; Cincotta AH Int J Mol Med; 2000 Apr; 5(4):349-55. PubMed ID: 10719049 [TBL] [Abstract][Full Text] [Related]
4. Effects of fructose and glucose on plasma leptin, insulin, and insulin resistance in lean and VMH-lesioned obese rats. Suga A; Hirano T; Kageyama H; Osaka T; Namba Y; Tsuji M; Miura M; Adachi M; Inoue S Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E677-83. PubMed ID: 10751202 [TBL] [Abstract][Full Text] [Related]
5. Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function. Liang Y; Luo S; Cincotta AH Metabolism; 1999 Oct; 48(10):1287-9. PubMed ID: 10535392 [TBL] [Abstract][Full Text] [Related]
6. Plasma leptin levels and triglyceride secretion rates in VMH-lesioned obese rats: a role of adiposity. Suga A; Hirano T; Inoue S; Tsuji M; Osaka T; Namba Y; Miura M; Adachi M Am J Physiol; 1999 Apr; 276(4):E650-7. PubMed ID: 10198300 [TBL] [Abstract][Full Text] [Related]
7. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Dube MG; Xu B; Kalra PS; Sninsky CA; Kalra SP Brain Res; 1999 Jan; 816(1):38-46. PubMed ID: 9878684 [TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinemia increases norepinephrine metabolism in the ventromedial hypothalamus of rats. Cincotta AH; Luo S; Liang Y Neuroreport; 2000 Feb; 11(2):383-7. PubMed ID: 10674491 [TBL] [Abstract][Full Text] [Related]
9. Distinct role of adiposity and insulin resistance in glucose intolerance: studies in ventromedial hypothalamic-lesioned obese rats. Kageyama A; Hirano T; Kageyama H; Osaka T; Namba Y; Tsuji M; Adachi M; Inoue S Metabolism; 2002 Jun; 51(6):716-23. PubMed ID: 12037724 [TBL] [Abstract][Full Text] [Related]
10. Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats. Shimazu T; Noma M; Saito M Brain Res; 1986 Mar; 369(1-2):215-23. PubMed ID: 2870775 [TBL] [Abstract][Full Text] [Related]
11. Circulating free fatty acids, insulin, and glucose during chemical stimulation of hypothalamus in rats. Steffens AB; Damsma G; van der Gugten J; Luiten PG Am J Physiol; 1984 Dec; 247(6 Pt 1):E765-71. PubMed ID: 6391199 [TBL] [Abstract][Full Text] [Related]
12. Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis. Bray GA Int J Obes; 1984; 8 Suppl 1():119-37. PubMed ID: 6398803 [TBL] [Abstract][Full Text] [Related]
13. Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters. Luo S; Meier AH; Cincotta AH Neuroendocrinology; 1998 Jul; 68(1):1-10. PubMed ID: 9695933 [TBL] [Abstract][Full Text] [Related]
14. Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus. Barnes MB; Lawson MA; Beverly JL Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1815-20. PubMed ID: 21957162 [TBL] [Abstract][Full Text] [Related]
15. Leptin receptor-expressing neurons in ventromedial nucleus of the hypothalamus contribute to weight loss caused by fourth ventricle leptin infusions. Seamon M; Ahn W; Li AJ; Ritter S; Harris RBS Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E586-E596. PubMed ID: 31361549 [TBL] [Abstract][Full Text] [Related]
16. Development of VMH obesity: in vivo insulin secretion and tissue insulin sensitivity. Pénicaud L; Kinebanyan MF; Ferré P; Morin J; Kandé J; Smadja C; Marfaing-Jallat P; Picon L Am J Physiol; 1989 Aug; 257(2 Pt 1):E255-60. PubMed ID: 2669518 [TBL] [Abstract][Full Text] [Related]
17. Resistance to adenovirally induced hyperleptinemia in rats. Comparison of ventromedial hypothalamic lesions and mutated leptin receptors. Koyama K; Shimabukuro M; Chen G; Wang MY; Lee Y; Kalra PS; Dube MG; Kalra SP; Newgard CB; Unger RH J Clin Invest; 1998 Aug; 102(4):728-33. PubMed ID: 9710441 [TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic consequences of endogenous hyperinsulinism in obese rats with lesions of the ventromedial hypothalamus]. Doaré L; Mesangeau D; Adli H; Germack R; Perret G; Valensi P Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1015-8. PubMed ID: 10989748 [TBL] [Abstract][Full Text] [Related]
19. In situ regulation of lipolysis by insulin and norepinephrine: a microdialysis study during euglycemic-hyperinsulinemic clamp. Cimmino M; Agosto A; Minaire Y; Géloën A Metabolism; 1995 Dec; 44(12):1513-8. PubMed ID: 8786716 [TBL] [Abstract][Full Text] [Related]
20. ICV vs. VMH injection of leptin: comparative effects on hypothalamic gene expression. Ambati S; Duan J; Choi YH; Hartzell DL; Della-Fera MA; Baile CA Behav Brain Res; 2009 Jan; 196(2):279-85. PubMed ID: 18926857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]